Cargando…
Mechanism of Huangqi Sanxian Decoction Inhibiting Osteoclast Differentiation Based on Network Pharmacology
Osteoclasts (OCs) have been the unique cell type exhibiting the bone-resorption activity in body. It is important to identify drugs to resist osteoclastogenesis to manage the bone-loss disorders. Huangqi Sanxian decoction (HQSXD) is utilized for the treatment of postmenopausal osteoporosis (PMOP) fo...
Autores principales: | Shi, Jian-Xin, Cai, Xiao-Qun, Zhao, Ze-Hao, Deng, Yu, Zhou, Zhi-Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225917/ https://www.ncbi.nlm.nih.gov/pubmed/35754697 http://dx.doi.org/10.1155/2022/8769531 |
Ejemplares similares
-
Antiosteoporotic Effects of Huangqi Sanxian Decoction in Cultured Rat Osteoblasts by Proteomic Characterization of the Target and Mechanism
por: Guo, Chong-Chong, et al.
Publicado: (2015) -
Network Pharmacology-Based Study of the Underlying Mechanisms of Huangqi Sijunzi Decoction for Alzheimer's Disease
por: Zhang, Wei, et al.
Publicado: (2021) -
Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking
por: Chen, Tingting, et al.
Publicado: (2022) -
Network Pharmacology Analysis on the Mechanism of Huangqi Sijunzi Decoction in Treating Cancer-Related Fatigue
por: Cui, Yixin, et al.
Publicado: (2021) -
Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis
por: Luo, Yan, et al.
Publicado: (2022)